Fora Capital, LLC Global Blood Therapeutics, Inc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $567,907 - $1.2 Million	17,528 New	17,528 $1.19 Million
Q2 2022 Aug 11, 2022	SELL	$22.3 - $37.39 $178,511 - $299,306	-8,005 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $205,568 - $284,897	8,005 New	8,005 $280,000
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $106,572 - $178,940	-2,187 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $91,241 - $190,706	2,187 New	2,187 $111,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.